U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 1% on Friday.
The Dow traded up 0.99% to 43,580.17 while the NASDAQ rose 1...
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 1% on Friday.
The Dow traded up 0.86% to 43,524.83 while the NASDAQ rose 1.46...
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 300 points on Friday.
Following the market opening Friday, the Dow traded up 0.76...
Shares of Taiwan Semiconductor Manufacturing Company Limited TSM rose sharply in today's pre-market trading after the company announced fourth-quarter results.
...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Monday.
The Dow traded up 0.08% to 42,765.84 whi...
U.S. stocks traded higher midway through trading, with the S&P 500 jumping more than 1% on Monday.
The Dow traded up 0.51% to 42,949.22 while the NASDAQ gained...
U.S. stocks traded higher this morning, with the Dow Jones index surging more than 200 points on Monday.
Following the market opening Monday, the Dow traded up...
PR NewswireTEL AVIV, Israel, Nov. 21, 2024
”“ BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to
Shares of Arcadium Lithium plc ALTM rose sharply in today's pre-market trading after the company confirmed non-binding acquisition approach by Rio Tinto.
Arcad...
The dynamics of the iron deficiency anemia market are anticipated to change in the coming years owing to the improvement in the research and development...
LOS ANGELES, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of...
/PRNewswire/ -- DelveInsight's 'Pancreatic Cancer Pipeline Insight – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...
DelveInsight’s pancreatic ductal adenocarcinoma pipeline report depicts a robust space with 40+ active players working to develop 50+ pipeline therapies...